NLRP3 and metabolic dysfunction-associated steatohepatitis: NLRP3 depleted mice are protected from a choline-deficient, L-amino defined (CDAA) diet-induced fibrosis and NASH, while transgenic mice with constitutive global NLRP3 activation develop fibrosis when placed on a short-term CDAA diet [130].